Axillary Nodal Burden in HER2+ and TNBC

NCT07211451 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1571

Last updated 2025-10-08

No results posted yet for this study

Summary

This study aimed to evaluated rates of pathologic axillary nodal metastasis in patients with with early-stage HER2-positive BC or TNBC who had clinically node-negative status on preoperative ultrasonography and underwent upfront breast-conserving surgery (BCS) with axillary surgery. In addition, this study aimed to identify subgroups in which SLNB omission may be feasible.

Conditions

Interventions

PROCEDURE

Breast conserving surgery with axillary surgery

In this study, all patients received breast conserving surgery with axillary surgery.

Sponsors & Collaborators

  • Gangnam Severance Hospital

    lead OTHER

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2025-08-31
Completion
2025-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07211451 on ClinicalTrials.gov